A team of researchers at the University of Warwick and Monash University has solved a puzzle that has stumped drug developers ...

PUNE: Weeks before Pune realtor Ketan Agarwal was allegedly pushed to his death from Lohagad Fort by his fiancée Siya Goyal ...

Microsoft plans to cut under 2.5% of its 220,000-person workforce next week, targeting sales, consulting, and Xbox roles amid ...

The U.S. Army veteran-operated maker of advanced photonic solutions will support U.S. Army's night fighting capability ...

Beauty's next frontier isn't a product, it's brain health, with science-backed rituals reshaping skincare and a wellness ...

Researchers have developed a way to program human cells to perform calculations and make autonomous decisions, similar to how ...

The Transportation Security Administration is initiating a new screening program for crew members, and airlines are paying ...

Taysha Gene Therapies (TSHA) remains a Buy on strong TSHA-102 Rett data, FDA-aligned pivotal path, and cash to 2028—read the ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

Lockton has signed a memorandum of understanding with CPA Australia in Shanghai, giving the insurance broker access to one of ...

Marc Boom, M.D., speaks with Donna Lynne, CEO of Denver Health, about how one of the nation's leading safety-net health systems is improving health outcomes by addressing housing insecurity, food ...